CANCER RESEARCH 2019 - 7th Edition of World Congress on Cancer Research, Survivorship and Management
View: 446
Website http://cancer.euroscicon.com/ |
Edit Freely
Category Top Cancer Conferences Europe, Middle East and Korea , Oncology Conferences Asia, USA, Europe, UK , Japan, Cancer Survivor Workshops, Cancer Awareness Events, Cancer Diagnosis Conferences Middle East, Cancer Therapy Conferences Australia
Deadline: May 11, 2019 | Date: August 22, 2019-August 23, 2019
Venue/Country: Tokyo, Japan
Updated: 2018-10-27 14:59:47 (GMT+9)
Call For Papers - CFP
It is our most prominent joy to welcome you to the official site of Cancer Research 2019, that goes for uniting the teachers, scientists, clinicians, instructors, program engineers to give a worldwide gathering to the spread of unique research results, new thoughts and viable advancement encounters which focus on both hypothesis and practices in our Therapeutic gatherings. The gathering will be on August 22-23, 2019 in Tokyo, Japan. The subject of the gathering is near, "Rising and Imaginative methodologies for the progression of disease treatment. Disease is a harmful development or a tumor coming about because of an uncontrolled division of cells. Malignancy is the second most regular reason for death in the European Association. Malignancy of the bosom and lung tumors is the main growth composes in European guys and females. The weight of new growth cases in 2010 was assessed to associate with 3 million, in European areas to 53% of this heap. The weight of tumor is expanding worldwide regardless of advances in growth finding and treatment. Notwithstanding, the overall growth insights delineate that 1 million grown-ups on the planet were determined to have disease and 1.7million passings happened in 2012 in Europe and 7.4 million internationally. Cancer is the most essential reason for death and horribleness in Europe after cardiovascular diseases. Cancer is as a rule avoidable, and early recognition builds the possibility of fix generously. Mostly every now and again happening types of the Cancer ailment in the EU are colorectal, bosom, prostate, and lung cancers. In men, lung cancer is the most continuous reason for cancer demise, while in ladies, it is bosom cancer. In the two people, colorectal cancer is the second most basic reason for cancer demise. Albeit noteworthy advances are being made in the battle against the infection, cancer remains a key general wellbeing concern and a colossal weight on European Cancer Societies. Cancer Statistics in Europe are in excess of 3 million new cases and 1.7 million passing every year, On-going Cancer conference speaks to the second most essential reason for death and dismalness in Europe. On a worldwide scale, cancer represented 7.4 million passing (around 13% of the aggregate) in 2017. Europe contains just a single eighth of the aggregate total populace, however, has around one-fourth of the worldwide aggregate of cancer cases: about 3.2 million new patients for each year and composes cancer meetings, oncology meetings in European nations.Conference tracksCancer ResearchCancer GeneticsCancer EpigeneticsCancer ScienceCancer DiagnosticsCancer Therapies & PreventionBiomarkersCancer Stem CellsBiopsyChemotherapyCancer ScreeningCancer ImmunotherapyCancer OperomicsCarcinogenesisCancer Nursing CareCancer AwarenessExperimental TherapeuticsOrgan Specific CancerRadiation TherapyCancer Alternative MedicineCancer SurvivorsMalignancy AggravationPersonalized Medicine
Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.